Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Human Pathology|June 1, 1996
The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinomaH Papadaki, S D Finkelstein, S Kounelis, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 8, 1998
The origin and molecular characterization of adenoid basal carcinoma of the uterine cervixM W Jones, S Kounelis, H Papadaki, et al.
The American Journal of Surgical Pathology|June 1, 1996
Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastomaH Papadaki, S Kounelis, S B Kapadia, et al.
Haematologica|July 1, 1993
Impaired release of natural killer cytotoxic factor(s) by peripheral blood lymphocytes in patients with chronic LGL-proliferative diseaseG D Eliopoulos, G Vaiopoulos, D Kyriakou, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 27, 2000
Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and human papillomavirus genotypingM W Jones, S Kounelis, H Papadaki, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 8, 1998
Prognostic value of p53 and K-ras-2 topographic genotyping in endometrial carcinoma: a clinicopathologic and molecular comparisonM W Jones, S Kounelis, C Hsu, et al.
Haematologia|January 1, 1997
Inhibition of mitogen-induced cellular cytotoxicity by serum from patients with multiple myelomaH Papadaki, J Konsolas, A Chatzivassili, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 1, 2015
Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomasE Prodromaki, A Korpetinou, E Giannopoulou, et al.
Frontiers in Medicine|October 30, 2023
Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter dataEleni Gavriilaki, Emmanuel Nikolousis, Eudoxia-Evaggelia Koravou, et al.
Pageof 2